AbelZeta Pharma is a global clinical-stage cell therapy company discovering, developing, and manufacturing T-cell-based immunotherapeutics for cancer and immunological diseases. Its pipeline centers on Chimeric Antigen Receptor (CAR)-T cell technology across hematologic malignancies, solid tumors, and inflammatory and immunological conditions. - View it on GitHub